97 related articles for article (PubMed ID: 23495258)
1. The role of phenethyl isothiocyanate on bladder cancer ADM resistance reversal and its molecular mechanism.
Tang K; Lin Y; Li LM
Anat Rec (Hoboken); 2013 Jun; 296(6):899-906. PubMed ID: 23495258
[TBL] [Abstract][Full Text] [Related]
2. PEITC reverse multi-drug resistance of human gastric cancer SGC7901/DDP cell line.
Tang T; Song X; Liu YF; Wang WY
Cell Biol Int; 2014 Apr; 38(4):502-10. PubMed ID: 23956061
[TBL] [Abstract][Full Text] [Related]
3. The chemopreventive agent phenethyl isothiocyanate sensitizes cells to Fas-mediated apoptosis.
Pullar JM; Thomson SJ; King MJ; Turnbull CI; Midwinter RG; Hampton MB
Carcinogenesis; 2004 May; 25(5):765-72. PubMed ID: 14729592
[TBL] [Abstract][Full Text] [Related]
4. Phenethyl isothiocyanate potentiates anti-tumour effect of doxorubicin through Akt-dependent pathway.
Eisa NH; ElSherbiny NM; Shebl AM; Eissa LA; El-Shishtawy MM
Cell Biochem Funct; 2015 Dec; 33(8):541-51. PubMed ID: 26548747
[TBL] [Abstract][Full Text] [Related]
5. The Reversal Effect and Its Mechanisms of Tetramethylpyrazine on Multidrug Resistance in Human Bladder Cancer.
Wang S; Lei T; Zhang M
PLoS One; 2016; 11(7):e0157759. PubMed ID: 27391608
[TBL] [Abstract][Full Text] [Related]
6. Benzyl isothiocyanate (BITC) and phenethyl isothiocyanate (PEITC)-mediated generation of reactive oxygen species causes cell cycle arrest and induces apoptosis via activation of caspase-3, mitochondria dysfunction and nitric oxide (NO) in human osteogenic sarcoma U-2 OS cells.
Wu CL; Huang AC; Yang JS; Liao CL; Lu HF; Chou ST; Ma CY; Hsia TC; Ko YC; Chung JG
J Orthop Res; 2011 Aug; 29(8):1199-209. PubMed ID: 21374707
[TBL] [Abstract][Full Text] [Related]
7. Phenethyl isothiocyanate enhances adriamycin‑induced apoptosis in osteosarcoma cells.
Fan Q; Zhan X; Xiao Z; Liu C
Mol Med Rep; 2015 Oct; 12(4):5945-50. PubMed ID: 26252906
[TBL] [Abstract][Full Text] [Related]
8. Phenethyl isothiocyanate inhibits migration and invasion of human gastric cancer AGS cells through suppressing MAPK and NF-kappaB signal pathways.
Yang MD; Lai KC; Lai TY; Hsu SC; Kuo CL; Yu CS; Lin ML; Yang JS; Kuo HM; Wu SH; Chung JG
Anticancer Res; 2010 Jun; 30(6):2135-43. PubMed ID: 20651362
[TBL] [Abstract][Full Text] [Related]
9. Phenethyl isothiocyanate induced apoptosis via down regulation of Bcl-2/XIAP and triggering of the mitochondrial pathway in MCF-7 cells.
Lee JW; Cho MK
Arch Pharm Res; 2008 Dec; 31(12):1604-12. PubMed ID: 19099231
[TBL] [Abstract][Full Text] [Related]
10. Phenethyl Isothiocyanate (PEITC) and Benzyl Isothiocyanate (BITC) Inhibit Human Melanoma A375.S2 Cell Migration and Invasion by Affecting MAPK Signaling Pathway
Ma YS; Hsiao YT; Lin JJ; Liao CL; Lin CC; Chung JG
Anticancer Res; 2017 Nov; 37(11):6223-6234. PubMed ID: 29061805
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with beta-phenylethyl isothiocyanate and curcumin.
Kim JH; Xu C; Keum YS; Reddy B; Conney A; Kong AN
Carcinogenesis; 2006 Mar; 27(3):475-82. PubMed ID: 16299382
[TBL] [Abstract][Full Text] [Related]
12. SOCS3 overexpression enhances ADM resistance in bladder cancer T24 cells.
Li MZ; Lai DH; Zhao HB; Chen Z; Huang QX; Situ J
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(13):3005-3011. PubMed ID: 28742207
[TBL] [Abstract][Full Text] [Related]
13. Tumor regression by phenethyl isothiocyanate involves DDB2.
Roy N; Elangovan I; Kopanja D; Bagchi S; Raychaudhuri P
Cancer Biol Ther; 2013 Feb; 14(2):108-16. PubMed ID: 23114715
[TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide in the mechanism of drug resistance reversal in MCF-7/ADM cell line of human breast cancer.
Wang X; Kong L; Zhao J; Yang P
Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):339-43. PubMed ID: 12408759
[TBL] [Abstract][Full Text] [Related]
15. Phenethyl isothiocyanate (PEITC) promotes G2/M phase arrest via p53 expression and induces apoptosis through caspase- and mitochondria-dependent signaling pathways in human prostate cancer DU 145 cells.
Tang NY; Huang YT; Yu CS; Ko YC; Wu SH; Ji BC; Yang JS; Yang JL; Hsia TC; Chen YY; Chung JG
Anticancer Res; 2011 May; 31(5):1691-702. PubMed ID: 21617228
[TBL] [Abstract][Full Text] [Related]
16. Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer.
Wang LG; Beklemisheva A; Liu XM; Ferrari AC; Feng J; Chiao JW
Mol Carcinog; 2007 Jan; 46(1):24-31. PubMed ID: 16921492
[TBL] [Abstract][Full Text] [Related]
17. Role and mechanisms of microRNA‑503 in drug resistance reversal in HepG2/ADM human hepatocellular carcinoma cells.
Wang D; Zhang N; Ye Y; Qian J; Zhu Y; Wang C
Mol Med Rep; 2014 Dec; 10(6):3268-74. PubMed ID: 25269574
[TBL] [Abstract][Full Text] [Related]
18. Tanshinone IIA acts via p38 MAPK to induce apoptosis and the down-regulation of ERCC1 and lung-resistance protein in cisplatin-resistant ovarian cancer cells.
Jiao JW; Wen F
Oncol Rep; 2011 Mar; 25(3):781-8. PubMed ID: 21165580
[TBL] [Abstract][Full Text] [Related]
19. Ursolic acid induces apoptosis via Akt/NF-κB signaling suppression in T24 human bladder cancer cells.
Gai L; Cai N; Wang L; Xu X; Kong X
Mol Med Rep; 2013 May; 7(5):1673-7. PubMed ID: 23483134
[TBL] [Abstract][Full Text] [Related]
20. Advances in molecular signaling mechanisms of β-phenethyl isothiocyanate antitumor effects.
Qin CZ; Zhang X; Wu LX; Wen CJ; Hu L; Lv QL; Shen DY; Zhou HH
J Agric Food Chem; 2015 Apr; 63(13):3311-22. PubMed ID: 25798652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
